-
Alabama pharmacy latest to ink partnership with Mark Cuban's Cost Plus Drug Co.
Mark Cuban's Cost Plus Drug. Co. is teaming up with Birmingham (Ala.) Apothecary to offer Team Cuban Cards beginning Nov. 1, Bham Now reported Oct. 20. -
Roche to buy autoimmune drugmaker from Pfizer, Roivant for $7B
Roche has agreed to acquire Telavant Holdings — the maker of an inflammatory bowel disease drug — from Roivant Sciences and Pfizer for $7.25 billion, the Switzerland-based company said in an Oct. 23 news release. -
Georgia 1st state to allow pharmacies to sell medical cannabis
By the end of the year, THC products will be available for purchase in some Georgia pharmacies, CNN reported Oct. 20. -
AI-created drugs fall off hype cycle
Biotech companies and drugmakers are shelving their AI-designed therapeutics after a series of clinical setbacks, Endpoints News reported Oct. 19. -
J&J dengue pill shows promise in trial
For the first time, an experimental antiviral for dengue virus showed efficacy in humans, Johnson & Johnson said Oct. 20. -
Pharma companies eye weight-loss drugs for kids
Eli Lilly and Novo Nordisk are working to get weight-loss drugs approved for children as young as 6, Bloomberg reported Oct. 20. -
CVS to stop stelling decongestants with phenylephrine
CVS is voluntarily pulling from its shelves some common decongestants that contain an active ingredient FDA advisors have deemed ineffective at relieving congestion. -
The rise of the chief pharmacy officer
Pharmacy leaders have already cracked the code of hospital C-suites, but increasingly, they're entering executive positions across health systems. -
1st study finds surge of weight loss drugs in health system
A California health system has noted an "exponential" increase in patients using Wegovy, Mounjaro and other similar drugs for weight loss, according to a first-of-its-kind study. -
Drugmaker to lay off 100+ after Biogen acquisition
Reata Pharmaceuticals — a rare disease drugmaker recently acquired by Biogen — filed a WARN notice Oct. 9, alerting Texas officials of its plans to cut 113 positions. The layoffs will take effect Nov. 27. -
Pharmacy group urges US to block Optum-Amedisys deal
Independent pharmacies and lawmakers are asking the federal government to probe UnitedHealth Group's proposed scoop of Amedisys, one of the largest home health and hospice care providers in the U.S. -
Hospitals push back on CMS' drug shortage solution
Hospital groups and healthcare think tanks are urging CMS to revise its proposal to address medication shortages, which have been persistent for decades and have struck multiple therapeutic areas in 2023. -
Pfizer sets list price for Paxlovid
Pfizer has set the list price for a five-day course of Paxlovid at $1,390, according to an exclusive report from The Wall Street Journal. -
OptumRx opens integrated pharmacy in Arizona
UnitedHealth Group's pharmacy care business OptumRx has opened a location in Mesa, Ariz., according to an Oct. 17 news release. -
Amazon begins prescription drone delivery in Texas
Amazon's pharmacy customers in College Station, Texas, can now receive their prescriptions via drone delivery in under an hour, the company announced Oct. 18. -
HHS, Pfizer begin commercialization plans for Paxlovid
Beginning in January, commercialization of Pfizer's Paxlovid antiviral medication will begin and could drive out-of-pocket prices north of $500 before insurance, according to CNN. -
The No. 1 priority among hospital pharmacy leaders
Similar to many healthcare sectors, staffing shortages are compounding issues for hospital pharmacy leaders, according to a LinkedIn poll conducted by Becker's. -
'Weight-loss drug wealth' shows up in charitable giving
Nonprofit foundations aligned with Eli Lilly and Novo Nordisk are now among the largest in the world due to surging sales of drugs like Ozempic, Wegovy and Mounjaro, The Wall Street Journal reports. -
Alzheimer's drug researcher accused of 'egregious misconduct'
Clinical trials for simufilam, an Alzheimer's drug made by Cassava Sciences, will continue even after one of its lead researchers has been accused of "long-standing and egregious misconduct in data management and record keeping," The New York Times reported Oct. 14. -
Cuban's Cost Plus partners with Alto Pharmacy to expand access
San Francisco-based Alto Pharmacy, will now accept Team Cuban Cards from Mark Cuban Cost Plus Drug Co., members, according to an Oct. 16 news release.
Page 21 of 50